Today: 20 March 2026
Subscribe
Browse Category

Cannabis Industry 8 October 2025 - 23 November 2025

Tilray Brands (TLRY) on November 23, 2025: Stock Under $1, Fresh AI Trading Signals, and a Tug-of-War Between Fundamentals and Regulation

Tilray Brands (TLRY) on November 23, 2025: Stock Under $1, Fresh AI Trading Signals, and a Tug-of-War Between Fundamentals and Regulation

Tilray Brands’ U.S. shares closed at $0.91 Friday, down 12% for the week and 56% below their 52-week high. Stock Traders Daily’s new AI-driven analysis rates TLRY “Weak” across all time frames, with key technical levels flagged between $1.12 and $1.47. Valueinvesting.io’s updated model assigns a fair value of –$7.67 per share, calling the stock “deeply overvalued.”
23 November 2025
··
Akanda Corp. (AKAN) Today: Full Cultivation License Push, Telecom Growth and Stock Reaction – November 14, 2025

Akanda Corp. (AKAN) Today: Full Cultivation License Push, Telecom Growth and Stock Reaction – November 14, 2025

Akanda Corp. announced plans to design and implement Health Canada–compliant security at its Gabriola Island cannabis facility, aiming for a full cultivation license. Shares rose about 9% to $1.41 in early U.S. trading after a multi-day slide. The company continues to operate Mexican telecom infrastructure while pursuing Canadian cannabis licensing. Akanda has extended its Gabriola Island option by two years.
14 November 2025
·
Canopy Growth (CGC) Lifts ‘Going Concern’ Doubts as Cash Tops Debt; Q2 FY2026 Shows 30% Canada Adult‑Use Growth

Canopy Growth (CGC) Lifts ‘Going Concern’ Doubts as Cash Tops Debt; Q2 FY2026 Shows 30% Canada Adult‑Use Growth

Canopy Growth reported Q2 FY2026 net revenue of C$66.7 million, up 6% year over year, and ended the quarter with C$298 million in cash, exceeding total debt by C$70 million. The company lifted its going-concern warning. Shares rose as much as 19% premarket before turning volatile. Operating loss narrowed to C$17 million, down 63% from a year ago.
7 November 2025
·
SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. shares fell 12% to $1.93 on Nov. 4 after reporting a Q3 net loss of C$11.1 million despite record free cash flow and 3.1% revenue growth to C$244.2 million. The stock is up about 10% year-to-date but down nearly 15% in the past month. SNDL holds C$240.6 million in cash and no debt. Analyst consensus remains “Hold” with a $2.50 price target.
4 November 2025
···
From Cannabis Clinics to Bitcoin Billions: KindlyMD (NAKA) Stock’s Wild 2025 Ride

From Cannabis Clinics to Bitcoin Billions: KindlyMD (NAKA) Stock’s Wild 2025 Ride

KindlyMD (NASDAQ: NAKA) shares soared 650% to $29 after merging with Bitcoin holding firm Nakamoto Holdings in August 2025, then crashed 96% to $0.65 amid dilution fears. The company raised $710 million to buy 5,744 BTC and filed for up to $5 billion in new stock sales. Recent loans and partnerships aim to refinance debt. Analysts remain split as NAKA trades near $1, with weak earnings and high volatility.
28 October 2025
····
Urban-gro Stock Skyrockets on Flashy Merger Deal – Is This the Cannabis Builder’s Comeback?

Urban-gro Stock Skyrockets on Flashy Merger Deal – Is This the Cannabis Builder’s Comeback?

Urban-gro, Inc. signed a binding letter of intent on Oct. 14, 2025, to merge with Flash Sports & Media, whose shareholders will own about 90% of the combined company. Urban-gro’s stock surged up to 60% intraday on the news but stayed below Nasdaq’s $1 minimum, leaving its listing in jeopardy. The company faces financial struggles, including defaulting on a $10 million credit line and settling a $1.49 million lawsuit.
14 October 2025
···
Tilray’s 300% Rally and Surprise Profit: Is the Cannabis Comeback Real?

Tilray’s 300% Rally and Surprise Profit: Is the Cannabis Comeback Real?

Tilray Brands posted record Q1 2026 revenue of $209.5 million and a surprise net profit of $1.5 million, sending shares up over 10% pre-market. The stock has quadrupled since July 2025, lifted by optimism over potential U.S. cannabis reform and recent political endorsements. Wall Street remains cautious, with a consensus “Hold” rating and a $1.90 price target. Volatility remains high as investors watch for policy changes and earnings updates.
9 October 2025
··
Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Is TLRY’s Rally Sustainable?

Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Is TLRY’s Rally Sustainable?

Tilray Brands shares have soared about 300% since July 2025, trading near $1.70–$1.80 after bipartisan U.S. support for marijuana decriminalization and Donald Trump’s endorsement of CBD. The company reports earnings Oct. 9, with analysts expecting a net loss of $0.03 per share on $206 million revenue. Tilray’s beverage sales rose 19% last year, while international medical cannabis revenue jumped 71% in the latest quarter.
8 October 2025
··
Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Will TLRY’s Rally Last?

Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Will TLRY’s Rally Last?

Tilray Brands shares surged nearly 300% since July 2025, peaking at $1.88 on September 29 after a White House video endorsed CBD and GOP senators backed cannabis rescheduling. The rally was fueled by a short squeeze, with trading volume jumping to 371 million shares. Despite the spike, Tilray reported a $1.26 billion loss in fiscal 2025 and shrinking core cannabis sales. The company holds $256 million in cash and has reduced debt.
8 October 2025
··
1 2

Stock Market Today

  • Silicon Motion (SIMO) Rises Despite Market Downturn, Strong Earnings Anticipated
    March 19, 2026, 7:45 PM EDT. Silicon Motion (SIMO) closed up 1.67% at $127.50, outperforming the S&P 500's 0.28% decline. Despite a 5.54% drop over the past month, SIMO is set for a significant earnings report, with analysts predicting $1.23 per share - a 105% year-over-year surge. Revenue is expected to reach $299.61 million, up nearly 80% from last year. Full-year projections show earnings of $5.8 per share and revenues hitting $1.27 billion, marking growth of 63% and 43% respectively. The stock holds a Zacks Rank #1 (Strong Buy), with recent upward estimate revisions signaling confidence. SIMO trades at a forward price-to-earnings (P/E) ratio of 21.61, slightly above its industry average, and maintains a PEG ratio of 0.77, matching its sector. The Computer - Integrated Systems industry ranks in the top 10%, underpinning favorable future performance prospects.
Go toTop